Dongxian Jiang

1.4k total citations
64 papers, 778 citations indexed

About

Dongxian Jiang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongxian Jiang has authored 64 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 36 papers in Surgery and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongxian Jiang's work include Esophageal Cancer Research and Treatment (31 papers), Gastric Cancer Management and Outcomes (16 papers) and Lung Cancer Treatments and Mutations (12 papers). Dongxian Jiang is often cited by papers focused on Esophageal Cancer Research and Treatment (31 papers), Gastric Cancer Management and Outcomes (16 papers) and Lung Cancer Treatments and Mutations (12 papers). Dongxian Jiang collaborates with scholars based in China and United States. Dongxian Jiang's co-authors include Yingyong Hou, Chen Xu, Robert J. Melamede, Susan S. Wallace, Zafer Hatahet, Jeffrey O. Blaisdell, Lijie Tan, Hai Wang, Haiying Zeng and Qi Song and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Dongxian Jiang

60 papers receiving 775 citations

Peers

Countries citing papers authored by Dongxian Jiang

Since Specialization

Citations

This map shows the geographic impact of Dongxian Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongxian Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongxian Jiang more than expected).

Fields of papers citing papers by Dongxian Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongxian Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongxian Jiang. The network helps show where Dongxian Jiang may publish in the future.

Co-authorship network of co-authors of Dongxian Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongxian Jiang. A scholar is included among the top collaborators of Dongxian Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongxian Jiang. Dongxian Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of SWI/SNF complex expression (SMARCA4, SMARCA2, SMARCB1, ARID1A) is associated with dMMR in primary adenocarcinoma of jejunum and ileum: A clinicopathological and molecular analysis based on the Chinese population 2025 ·Pathology - Research and Practice ·(unknown), Rongkui Luo, Huimei Wang, Aytursun Abuduwaili, Dongxian Jiang, (unknown), Lei Xu, (unknown), Zhiping Niu, (unknown), Xu Chen, (unknown)	0
2	Integrated proteogenomic characterization of ampullary adenocarcinoma 2025 ·Cell Discovery ·Qiao Zhang, Xiaomeng Xu, Dongxian Jiang, Yunzhi Wang, Hai Wang, Jiajun Zhu, (unknown), Ronghua Wang, (unknown), Kai Li, Jinwen Feng, Xiang Hang, (unknown), Ning Xu, (unknown), (unknown), Yu Liu, Yingyong Hou, Chen Ding	0
3	CPZ 2025 ·The American Journal of Surgical Pathology ·(unknown), Rongkui Luo, Lingli Chen, Huimei Wang, (unknown), Qi Song, Dongxian Jiang, Lei Xu, (unknown), Xu Chen, (unknown)	1
4	Positive Lymph Node Status Before and After Neoadjuvant Chemoradiotherapy Improves Prediction of Disease-Free Survival in Esophageal Squamous Cell Carcinoma Patients 2025 ·Annals of Surgical Oncology ·Xu Huang, (unknown), (unknown), (unknown), Dongxian Jiang, (unknown), Zhaoyun Duan, (unknown), (unknown), Qingle Wang, Zhao‐Chong Zeng, Hong Fan, Hongbo Xü, Jun Yin, (unknown), Han Tang, Lijie Tan, Miao Lin	1
5	Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression 2024 ·Cancer Research ·Lingling Li, Dongxian Jiang, (unknown), (unknown), Qiao Zhang, (unknown), (unknown), (unknown), Jinwen Feng, Subei Tan, Wen Huang, (unknown), Chen Xu, Chen‐Ying Liu, Wei Yu, Yingyong Hou, Chen Ding	3
6	HLA-A+ tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma 2024 ·British Journal of Cancer ·Dandan Zhang, Dongxian Jiang, Liping Jiang, (unknown), Xiaobing Wang, (unknown), (unknown), (unknown), (unknown), Jie Wang, (unknown), Wenqing Qiu, (unknown), (unknown), Yuchen Jiao, Yun Liu, Zhihua Liu	11
7	ASO Visual Abstract: Development and Validation of PET/CT-Based Nomogram for Preoperative Prediction of Lymph Node Status in Esophageal Squamous Cell Carcinoma 2024 ·Annals of Surgical Oncology ·Shaoyuan Zhang, (unknown), (unknown), Guobing Liu, Dongxian Jiang, Jun Yin, Yong Fang, Hao Wang, Yaxing Shen, Yingyong Hou, Hongcheng Shi, Lijie Tan	1
8	Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies 2023 ·Cell Reports Medicine ·Yan Li, (unknown), (unknown), Dongxian Jiang, Ying Wang, (unknown), Subei Tan, Jinwen Feng, Yunzhi Wang, Zhaoyu Qin, (unknown), (unknown), (unknown), Xu Chen, Jiaxue Wu, Jianmin Xu, Yingyong Hou, Chen Ding	16
9	Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China 2022 ·Diagnostic Pathology ·Chen Xu, Miaomiao Sun, Hongfang Jin, Zengshan Li, Rong Qin, Guoping Ren, Wenyong Sun, Lirong Chen, (unknown), Yalan Liu, Dongxian Jiang, Lingli Chen, Rongkui Luo, Yingyong Hou	4
10	The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China 2022 ·Surgical Endoscopy ·Xuemin Xue, Qi Sun, Dongxian Jiang, Xinran Wang, Yong Liu, (unknown), (unknown), Na Cheng, Guiqi Wang, Yueping Liu, Yingyong Hou, Xiangshan Fan, Liyan Xue	1
11	HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma 2022 ·Frontiers in Genetics ·Lingli Chen, Lei Xu, (unknown), Rongkui Luo, Dongxian Jiang, Yueqi Wang, Wei Li, Yingyong Hou	6
12	Identification of clinical prognostic features of esophageal cancer based on m6A regulators 2022 ·Frontiers in Immunology ·Huimei Wang, Yiping Zhang, Lin Chen, Yufeng Liu, (unknown), Dongxian Jiang, (unknown), Haixing Wang, Liyan Wang, Yu Lin, Yuanmei Chen, Junqiang Chen, Yuanji Xu, Yingyong Hou	14
13	HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer 2021 ·Pathology - Research and Practice ·Yalan Liu, Lingli Chen, Dongxian Jiang, (unknown), Jie Huang, Yingyong Hou, Chen Xu	8
14	CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome 2021 ·Frontiers in Genetics ·(unknown), Xiang Wang, Xue Zhang, Weijie Chen, (unknown), Qi Song, Hao Wang, Jia Liu, Lei Xu, Yifan Xu, (unknown), Lijie Tan, Dongxian Jiang, (unknown), Yingyong Hou	6
15	Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy 2020 ·Journal of Thoracic and Cardiovascular Surgery ·Han Tang, Dongxian Jiang, Shumin Zhang, Zhao‐Chong Zeng, Lijie Tan, Yingyong Hou, Qun Wang, Hao Wang, (unknown), Yaxing Shen, Jun Yin, Di Ge	18
16	Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma 2018 ·Human Pathology ·Jie Huang, Qi Song, Hao Wang, Hai Wang, Chen Xu, Xin Wang, (unknown), (unknown), Yifan Xu, (unknown), Haiying Zeng, Lijie Tan, Hongguang Zhu, Dongxian Jiang, Yingyong Hou	7
17	HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks 2017 ·Histopathology ·Chen Xu, Yalan Liu, Dongxian Jiang, Xiaowen Ge, Ying Zhang, (unknown), Haiying Zeng, Jie Huang, Yuan Ji, Jun Hou, Yihong Sun, Kuntang Shen, Tianshu Liu, Yingyong Hou, Jing Qin	6
18	PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor 2016 ·Laboratory Investigation ·Yuan Shi, (unknown), Qin Hu, Xiaojing Li, Jianfang Xu, Shaohua Lu, Yalan Liu, Chen Xu, Dongxian Jiang, (unknown), (unknown), Yun-shan Tan, Kuntang Shen, Yingyong Hou	31
19	Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies 2014 ·Genetics and Molecular Research ·(unknown), Dongxian Jiang, (unknown), (unknown), (unknown), Li-Fang Yu	5
20	Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor 2013 ·Diagnostic Pathology ·Dongxian Jiang, Deming He, Yingyong Hou, Weiqi Lu, Yuan Shi, Qin Hu, Shaohua Lu, Chen Xu, Yalan Liu, (unknown), Yun-shan Tan, Xiongzeng Zhu	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact